WESPAC Advisors SoCal’s Invesco Pharmaceuticals ETF PJP Stock Holding History

WESPAC Advisors SoCal’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20	Closed	-$1K	–	238
2019 Q1	$1K	Buy	+20	New	+$1.31K	﹤0.01%	324
2018 Q4	–	Hold	0	–	–	–	322
2018 Q3	–	Hold	0	–	–	–	296
2018 Q2	–	Sell	-20	Closed	-$1K	–	206
2018 Q1	$1K	Hold	20	–	–	﹤0.01%	259
2017 Q4	$1K	Hold	20	–	–	﹤0.01%	244
2017 Q3	$1K	Hold	20	–	–	﹤0.01%	254
2017 Q2	$1K	Hold	20	–	–	﹤0.01%	233
2017 Q1	$1.18K	Hold	20	–	–	﹤0.01%	237
2016 Q4	$1.12K	Hold	20	–	–	﹤0.01%	246
2016 Q3	$1.23K	Hold	20	–	–	﹤0.01%	268
2016 Q2	$1.27K	Hold	20	–	–	﹤0.01%	263
2016 Q1	$1.2K	Sell	20 -50	-71%	-$3.06K	﹤0.01%	270
2015 Q4	$4K	Buy	+70	New	+$4.96K	﹤0.01%	226

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

WESPAC Advisors SoCal's PJP Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2019, closing a stake of 20 shares — an estimated $1K sold.

WESPAC Advisors SoCal first reported a position in PJP in Q4 2015 and held it in 11 quarters. The position peaked at $4K in Q4 2015. 83 funds tracked by Wall St. Rank hold PJP as of Q2 2019.

WESPAC Advisors SoCal reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
WESPAC Advisors SoCal sold 20 Invesco Pharmaceuticals ETF shares in Q2 2019, an estimated $1K.
WESPAC Advisors SoCal first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and held it in 11 quarters.
WESPAC Advisors SoCal's Invesco Pharmaceuticals ETF position peaked at $4K in Q4 2015.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.